8:30 Tdap Adolescent Recommendation 

Pertussis Working Group Update 

Adolescent Pertussis and Tdap 

Tetanus and diphtheria containing vaccines 

 Safety monitoring 

 Supply, planned studies 

Use of Tdap among adolescents 11-18 years 

 

10:30 BREAK 

 

 

 

 

 

 

Dr. J. Seward (NIP) 

	 


 

CENTERS FOR DISEASE CONTROL AND PREVENTION (Final 6-27-05) 

ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES 

MARRIOTT CENTURY CENTER HOTEL 

ATLANTA, GEORGIA 

JUNE 29-30, 2005 

AGENDA ITEM 

June 29 

8:00 Welcome 

11:00 Hepatitis B Vaccine Recommendation 

 Childhood recommendations 

12:30 LUNCH 

1:30 Recommendations for Use of Hepatitis A 

2:30 	 MMRV Working Group/Introduction 

 Overview of Varicella Epidemiology

 Physician survey results 

 

3:30 BREAK 

4:00 Update cost-effectiveness analysis

 Summary of AAP recommendations

Votes 

Routine 2nd dose vaccination at 4-6 yrs of age 

Catch-up vaccination with 2nd dose of children 

 7-12 yrs of age who have only rec’d 1 dose 

School-entry requirements for middle and high 

 schools and colleges 

Vaccination of susceptible persons > years of 

age 

Routine screening of pregnant women & post-

 partum vaccination of susceptible women 

Expanding recommendation on vaccination of 

 HIV (+) children 

 

Discussion & Vote 

Discussion & Vote 

Discussion & Vote 

Discussion & Vote 

Discussion & Vote 

Discussion & Vote 

PURPOSE/ACTION 

Information 

Information 

Information 

Information

Information

Decision 

 VFC Vote

Information 

Discussion 

 Decision

Information 

Discussion

Information 

PRESIDER/PRESENTER(s) 

 Dr. M. Levin (Chair, ACIP) 

 Dr. L. Pickering (CDC, OD) 

Dr. J. Abramson (ACIP) 

Dr. M. Cortese (NIP) 

Dr. T. Murphy (NIP) 

Dr. J. Iskander (OD) 

TBD (GSK, Sanofi Pasteur) 

Dr. K. Broder (NIP) 

Dr. G. Wallace (NIP) 

Dr. E. Mast (NCID) 

Dr. B. Bell (NCID) 

 Dr. G. Armstrong (NCID) 

Dr. J. Campbell (ACIP) 

 Dr. D. Guris (NIP) 

 Dr. Marin (NIP) 

 Dr. F. Zhou (NIP) 

 Dr. C. Meissner (Tufts) 

Note: * These votes will be taken only if appropriate in light of prior decisions by or ACIP. 
 

 Second dose varicella

 

 

8:30 Disease burden and epidemiology 

 zoster vaccine trial results 

Zoster vaccine clinical trial results 

 

9:15 Tdap – Use in Adults 

Epidemiology of pertussis in adults 

Potential strategies using Tdap – Overview 

Information 

Discussion 

 

 

 

 

 

 

 

 

 

 *Discussion & Vote (VFC) Dr. G. Wallace (NIP) 

5:30	 	 General Recommendations Work Group : 

 Vaccine storage and handling 

Information Dr. A. Kroger (NIP) 

6:15	 	 Revised Adult Immunization Schedule Information 

Decision

Dr. R. Strikas (NIP) 

 

6:30 Public Comment 

6:45 ADJOURN

AGENDA ITEM PURPOSE/ACTION PRESIDER/PRESENTER(s) 

June 30 

8:00 Unfinished Business

Information 

Information 

Discussion 

TBD 

Dr. P. Annunziato (Merck)

 

Dr. K. Kretsinger (NIP) 

Dr. T. Murphy (NIP) 

10:15 BREAK 

10:45 Human Papilloma Virus Workgroup Overview 

 HPV natural history 

 Cervical cancer epidemiology, Pap 

 screening and burden of disease 

 HPV vaccine cost-effectiveness

Information Dr. L. Markowitz (NCHSTP) 

Dr. B. Unger (NCID) 

Dr. H. Lawson (NCCDPHP) 

Dr. S. Goldie (Harvard) 

 

 

12:30 LUNCH 

1:30 ACIP/NVAC Joint Working Group: 

 Preliminary results on pandemic vaccine 

 prioritization 

Information 

Discussion 

 

Dr. C. Bridges (NIP) 

2:15 ACIP/HICPAC joint statement on 

 immunization of health care workers 

against influenza 

Discussion 

Decision 

Dr. M. Pearson (HICPAC/NCID) 

2:30 The effectiveness of an investigational 

 pentavalent (Human-Bovine) reassortant 

 rotavirus vaccine (PRV) to reduce health 

 care utilization for rotavirus gastroenteritis 

Information Dr. P. Heaton (Merck) 

Issues concerning the rotateq vaccine Information Dr. U. Parashar (NIP) 

Note: * These votes will be taken only if appropriate in light of prior decisions by or ACIP. 
3:00 HIV Vaccine Working Group Update Information 

 Discussion 

Dr. G. Birkhead (ACIP) 

3:10 Updates: Ex-officios and CDC 

3:20 Public Comment

3:35 ADJOURN 

 

Note: * These votes will be taken only if appropriate in light of prior decisions by or ACIP.